tirzepatide dry eye Zepbound Syndrome: An Authoritative Patient Guide [2025] Use of the dual GIP/GLP-1
Description
Generic : If a generic version of Mounjaro becomes available in the future, it could lower the cost compared to the brand-name medication
doi: 10.7326/M23-2718 [DOI] [PMC free article] [PubMed] [Google Scholar] 25.Wang W, Volkow ND, Wang Q, et al
![tirzepatide dry eye Zepbound Syndrome: An Authoritative Patient Guide [2025] Use of the dual GIP/GLP-1](https://www.laxmieye.org/blog/wp-content/uploads/2025/05/laxmi-eye-dry-eye-treatment.png)
(2018) Mol Metab Willard et al
![tirzepatide dry eye Zepbound Syndrome: An Authoritative Patient Guide [2025] Use of the dual GIP/GLP-1](https://www.bmimd.com/wp-content/uploads/2026/03/Tirzepatide-Non-Microdose-Mockup-scaled-e1773759579158.png)
The pathophysiology is unclear, but risk factors are thought to be the same as the type 1 diabetic patients who rapidly improved A1c in the Diabetes Control and Complications Trial: long duration of diabetes mellitus, long duration of poor glycemic control, worse baseline level of DR prior to treatment and magnitude of reduction in A1c after treatment
![tirzepatide dry eye Zepbound Syndrome: An Authoritative Patient Guide [2025] Use of the dual GIP/GLP-1](https://classactionlawyertn.com/wp-content/uploads/2026/03/ezgif-74de9e61396bb39f-1.webp)
Two side-effect themes that are commonly discussed online but not labeled in the FDA prescribing information are vivid dreams (post-marketing case reports only) and facial volume loss both are observed across rapid weight loss generally, not unique to tirzepatide